Real-world experience versus clinical trials: pros and cons in psoriasis therapy evaluation

被引：20

作者：

Cinelli, Eleonora ^{[1
]}

Fabbrocini, Gabriella ^{[1
]}

Megna, Matteo ^{[1
]}

机构：

[1] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 2022年 / 61卷 / 03期

关键词：

D O I：

10.1111/ijd.15644

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E107 / E108

页数：2

共 4 条

[1] Supplement: Ageing Research in Chinese Societies Preface [J].

Chen, Liang-Kung .

AGEING RESEARCH REVIEWS, 2010, 9 :S1-S1

[2] Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development [J].

Kirsten, N. ;

Livideanu, C. Bulai ;

Richard, M. A. ;

Konstantinou, M. P. ;

Khemis, A. ;

Balluteaud, C. ;

Goujon, C. ;

Beylot-Barry, M. ;

Paul, C. .

BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (03) :636-638

[3] Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules" [J].

Megna, Matteo ;

Balato, Anna ;

Napolitano, Maddalena ;

Gallo, Lucia ;

Caso, Francesco ;

Costa, Luisa ;

Balato, Nicola ;

Scarpa, Raffaele .

CLINICAL RHEUMATOLOGY, 2018, 37 (07) :1739-1741

[4] Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naive patients from the French National Health Insurance database (SNIIRAM) [J].

Sbidian, E. ;

Mezzarobba, M. ;

Weill, A. ;

Coste, J. ;

Rudant, J. .

BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) :86-93

← 1 →